Non-Exudative Macular Neovascularization: A 2-Year Follow-up Study Assessing the Progression of Retinal Pigment Epithelium and Outer Retinal Atrophy
DOI:
https://doi.org/10.48560/rspo.38320Keywords:
Geographic Atrophy, Macular Degeneration, Retinal Pigment Epithelium, Tomography, Optical Coherence, Visual AcuityAbstract
INTRODUCTION: Advanced age-related macular degeneration (AMD) includes exudative and atrophic phenotypes. Non-exudative macular neovascularization (NE-MNV) has been linked to smaller areas of geographic atrophy (GA), suggesting it may slow the progression of complete retinal pigment epithelium and outer retinal atrophy (cRORA). This study aims to determine whether NE-MNV affects the prevalence and progression of cRORA over two years.
METHODS: This observational study included 65 patients with unilateral exudative AMD, assessing 2-year cRORA progression and exudative conversion in the fellow eye. Patients were grouped based on the presence (NE-MNV) or absence (no NE-MNV) of NE-MNV. The prevalence and progression of tomographic cRORA, GA on fundus autofluorescence (FAF), cRORA greatest linear diameter (GLD), GA area, and exudative conversion rates were compared.
RESULTS: Sixty-five patients were included in our cohort. The prevalence of NE-MNV was 24.6% (n=16). We identified a 33% bilateral exudative conversion rate (n=4) in the NE-MNV group and a 16.9% conversion rate in the eyes without NE-MNV (n=9) over the 2-year period (p=0.036). Eyes with NE-MNV had proportionally more frequent tomographic signs of atrophy (47.3% vs 31.3% in eyes without NE-MNV; p=0.535) and a smaller cRORA GLD (958.50±348 vs 2629.46±2124.72, p=0.008) compared to eyes without NE-MNV. cRORA was present in 11 eyes (30.6%) without NE-MNV and 2 eyes (12.5%) with NE-MNV (p=0.118). There were no significant differences in FAF GA prevalence (2 eyes out of 16 and 11 eyes out of 36, respectively; p=0.118) or GA area (p=0.186) or GA progression rate (p=0.125) between groups.
CONCLUSION: In our study, the presence of NE-MNV was not associated with the prevalence of cRORA and/or FAF GA after a 2-year follow-up. Nonetheless, eyes with NE-MNV presented smaller cRORA GLD, corroborating that NE-MNV may prevent the progression of cRORA. One-third of the eyes with NE-MNV converted to exudative AMD over 2 years. Extended monitoring is required to confirm these results at long term.
Downloads
References
Vyawahare H, Shinde P. Age-related macular degeneration: epidemiology, pathophysiology, diagnosis, and treatment. Cureus. 2022;14:e29583. doi: 10.7759/cureus.29583.
Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, et al. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 2022;9:62-79. doi: 10.1016/j.gendis.2021.02.009.
Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology. 2020;127:616-36. doi: 10.1016/j.ophtha.2019.11.004.
Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology. 1985;92:615-27.
Faatz H, Rothaus K, Ziegler M, Book M, Heimes-Bussmann B, Pauleikhoff D, et al. Vascular analysis of type 1, 2, and 3 macular neovascularization in age-related macular degeneration using swept-source optical coherence tomography angiography shows new insights into differences of pathologic vasculature and may lead to a more personalized understanding. Biomedicines. 2022;10:694. doi: 10.3390/biomedicines10030694.
Motulsky EH, Zheng F, Shi Y, Gregori G, Rosenfeld PJ. Anatomic Localization of Type 1 and Type 2 Macular Neovascularization Using Swept- Source OCT Angiography. Ophthalmic Surg Lasers Imaging Retina. 2018;49:878-86. doi: 10.3928/23258160-20181101-09.
Rosenfeld PJ. Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2016;57:14-26.
Mehta H, Tufail A, Daien V, Lee AY, Nguyen V, Ozturk M, et al. Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res. 2018;65:127-46. doi: 10.1016/j.preteyeres.2017.12.002.
Khan H, Aziz AA, Sulahria H, Khan H, Ahmed A, Choudhry N, et al. Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration. Clin Ophthalmol. 2023;17:321-7. doi: 10.2147/OPTH.S367089.
Laiginhas R, Yang J, Rosenfeld PJ, Falcao M. Nonexudative macular neovascularization - a systematic review of prevalence, natural history, and recent insights from OCT angiography. Ophthalmol Retina. 2020;4:651-61. doi: 10.1016/j.oret.2020.02.016.
Vilares-Morgado R, Silva I, Cunha AM, Carneiro A, Falcao-Reis F, Falcao M. Prevalence and Area of Retinal Pigment Epithelium and Outer Retinal Atrophy in Eyes with Non-Exudative Macular Neovascularization. Ophthalmologica. 2022;245:528-37. doi: 10.1159/000525978.
Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology. 2018;125:537-48. doi: 10.1016/j.ophtha.2017.09.028.
Guymer RH, Rosenfeld PJ, Curcio CA, Holz FG, Staurenghi G, Freund KB, et al. Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. Ophthalmology. 2020;127:394-409. doi: 10.1016/j.ophtha.2019.09.035.
Staurenghi G, Sadda S, Chakravarthy U, Spaide RF. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN • OCT consensus. Ophthalmology. 2014;121:1572-8. doi: 10.1016/j.ophtha.2014.02.023.
Holz FG, Sadda SR, Staurenghi G, Lindner M, Bird AC, Blodi BA, et al. Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology. 2017;124:464-78. doi: 10.1016/j.ophtha.2016.12.002.
de Oliveira Dias JR, Zhang Q, Garcia JMB, Zheng F, Motulsky EH, Roisman L, et al. Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography. Ophthalmology. 2018;125:255-66. doi: 10.1016/j.ophtha.2017.08.030.
Treister AD, Nesper PL, Fayed AE, Gill MK, Mirza RG, Fawzi AA. Prevalence of Subclinical CNV and Choriocapillaris Nonperfusion in Fellow Eyes of Unilateral Exudative AMD on OCT Angiography. Transl Vis Sci Technol. 2018;7:19. doi: 10.1167/tvst.7.5.19.
Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I, et al. Incidence of Fellow Eye Involvement in Patients With Unilateral Exudative Age-Related Macular Degeneration. JAMA Ophthalmol. 2018;136:905-11. doi: 10.1001/jamaophthalmol.2018.2154.
Heiferman MJ, Fawzi AA. Progression of subclinical choroidal neovascularization in age-related macular degeneration. PLoS One. 2019;14:e0217805. doi: 10.1371/journal.pone.0217805.
Capuano V, Miere A, Querques L, Sacconi R, Carnevali A, Amoroso F, et al. Treatment-Naive Quiescent Choroidal Neovascularization in Geographic Atrophy Secondary to Nonexudative Age-Related Macular Degeneration. Am J Ophthalmol. 2017;182:45-55. doi: 10.1016/j.ajo.2017.07.009.
Bailey ST, Thaware O, Wang J, Hagag AM, Zhang X, Flaxel CJ, et al. Detection of Nonexudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using OCT Angiography. Ophthalmol Retina. 2019;3:629-36. doi: 10.1016/j.oret.2019.03.008.
Korb CA, Elbaz H, Schuster AK, Nickels S, Ponto KA, Schulz A et al. Five-year cumulative incidence and progression of age-related macular degeneration: results from the German population-based Gutenberg Health Study (GHS). Graefes Arch Clin Exp Ophthalmol. 2022;260:55-64. doi: 10.1007/s00417-021-05312-y.
Farinha CVL, Cachulo ML, Alves D, Pires I, Marques JP, Barreto P et al. Incidence of Age-Related Macular Degeneration in the Central Region of Portugal: The Coimbra Eye Study - Report 5. Ophthalmic Res. 2019;61:226-35. doi: 10.1159/000496393.
Ehlers JP, McConville C, Yordi S, Cetin H, Cakir Y, Kalra G, et al. Correlation Between Blue Fundus Autofluorescence and SD-OCT Measurements of Geographic Atrophy in Dry Age-Related Macular Degeneration. Am J Ophthalmol. 2024;266:92-101. doi: 10.1016/j.ajo.2024.04.031.
Fernandes AR, Zielinska A, Sanchez-Lopez E, Dos Santos T, Garcia ML, Silva AM, et al. Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options. Int J Mol Sci. 2022;23:2592. doi: 10.3390/ijms23052592.
Heesterbeek TJ, Lores-Motta L, Hoyng CB, Lechanteur YT, den Hollander AI. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt. 2020;40:140-70. doi: 10.1111/opo.12675.
Yang J, Zhang Q, Motulsky EH, Thulliez M, Shi Y, Lyu C, et al. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography. Am J Ophthalmol. 2019;208:1-11. doi: 10.1016/j.ajo.2019.06.017.
Sohn EH, Flamme-Wiese MJ, Whitmore SS, Workalemahuu G, Marneros AG, Boese EA, et al. Choriocapillaris Degeneration in Geographic Atrophy. Am J Pathol. 2019;189:1473-80. doi: 10.1016/j.ajpath.2019.04.005.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Sociedade Portuguesa de Oftalmologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file, click here
